Addiction Conferences 2019 | Addiction Conference | Behavioral Health Conferences 2019 | International Addiction Conferences 2019 | Addiction Medicine Conference

We are not affiliated with any third parties to book your accommodation. All delegates and speakers are advised to book only through official event website.

About GAB 2019

Magnus Group is honored to welcome you to attend the "Global Conference on Addiction Medicine and Behavioral Health" scheduled on August 22-24, 2019 in London, UK.

Aim and Scope: GAB 2019 is an international meeting ground focused on neuroscience contributions and it aims to advance the understanding of the action of drugs of abuse and addictive processes. The conference encourages research on the etiology, prevention, identification, and treatment of substance abuse; thus, providing a forum for the dissemination of information in the extensive field of addiction. GAB gives the participants direct access to the most significant and current research findings on the nature and management of alcoholism and alcohol-related disorders.

Abstracts are accepted in both animal experimentation and clinical research whose content is geared towards behavioral, psychological, genetic, neuro-biological, pharmacological, biomedical, epidemiological, and sociological perspectives in the field. GAB 2019 particularly encourages the submission of abstracts which have a harm reduction perspective. However, all philosophies related to the field will find a place in the event.

Scientific Sessions

Addiction Psychiatry and Mental Health
Drug Addiction and Substance Abuse
Alcoholism and Dependence
Addiction and Youth
Child & Adolescent Substance Abuse
Substance abuse treatment, prevention and policy
Pharmacology of Drug addiction
CNS and Addictive Disorders
Cannabis and Opioid addiction
Addiction Therapy
Addiction Medicine
Addiction : Nursing
Addiction Rehabilitation & Recovery
Addiction and Criminology
Behavioral medicine and Counseling
Alternative Approaches towards Addiction
Clinical Case Reports
New Insight in Addiction Research
Addiction - From Animal models to Case studies
Dual Diagnosis - Mental Illness co-occurring with Substance Abuse

Submit Your Abstract

Scientific Committee Members

Ambros Uchtenhagen

Zurich University, Switzerland

Sam Vaknin

Southern Federal University, Russia

Rajendra D. Badgaiyan

Icahn School of Medicine at Mount Sinai, USA

Leo O. Lanoie

Saskatchewan Health Authority, North East Area, Canada

Jaime Senabre

University of Alicante, Spain

View All Scientific Committee Members

Our Speakers

Selvinaz Sacan
Aydin Adnan Menderes University, Turkey
Scott Giacomucci
Phoenix Center for Experiential Trauma Therapy, USA
Tamarah L. Gehlen
Augsburg University, USA
Mary Lynn Mathre
Patients Out of Time, USA
Ying Ying Leung
Middlesex University, Hong Kong
Martin Haraldsen
General Practitioner, Norway
Hattie Moyes
The Forward Trust, UK
Danilo Tittarelli
Mental Health Department and Addiction Department, Italy
Laurence Armand French
University of New Hampshire, Durham, USA
Jonathan Chick
Consultant Psychiatrist and Medical Director, Castle Craig Hospital, UK
Xiaowei Guan
Vice Dean of School of Medicine and Life Sciences, China
Matthew Jones
Swansea University Medical School, UK

View All Speakers

Collaboration Partners

Past Conference Information 2017

Magnus Group takes a great pride in announcing the success of “International Conference on Neurology and Brain Disorders” (INBC 2017) which was held in Valencia, Spain, during 26-28 June, 2017.

Neurology Congress 2017 witnessed a combination of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled issues related to the field of Neurology. The extremely illustrious conference hosted by Magnus Group was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing their countries around the world.

For INBC 2017 Final Program: Click Here

For INBC 2017 Gallery: Click Here

Organizing Committee of Neurology Conference 2017:

Giuseppe Scalabrino	University of Milan	Italy
Harry W.M. Steinbusch	Maastricht University	The Netherlands
Pankaj Sharma	University of London	UK
Henry Bakunts	International Medical Centre “”STROKE””	Republic of Armenia
Mira Rakacolli-Kapisyzi	President of Albanian Society of Neurology	Albania
Serhiy Forostyak	Charles University	Czech Republic

The Organizing Committee would like to thank the moderators Dr. Leonardo Pignataro, Columbia University-City University of New york-CSI, USA, Dr. Udai Pandey, University of Pittsburgh Medical Center, USA, Michael Ugrumov, Institute of Development Biology RAS, Russia for their offerings which resulted in smooth functioning of the conference.

The conference was boarded with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The best Part of the conference were the keynote forum by prominent scientists, gave their profitable contributions in the form of highly enlightening presentations and made the conference a best notch one.

Keynote speakers:

Sergi Ferre	National Institute on Drug Abuse(NID, NIH)	USA
Marisela Morales	National Institute on Drug Abuse(NID, NIH)	USA
Giuseppe Scalabrino	University of Milan	Italy
Harry W.M. Steinbusch	Maastricht University	The Netherlands
Pankaj Sharma	University of London	UK
Mira Rakacolli-Kapisyzi	President of Albanian Society of Neurology	Albania
Henry Bakunts	International Medical Centre “STROKE”	Armenia

Magnus Group is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on engross the plenary sessions, workshops, and special sessions in an expanded manner to make this conference a privileged Summit.

Neurology Conference 2017 Speaker Line Up:

Day 1: Speakers

Michel Baudry	Western University of Health Sciences	USA
Miranda N. Reed	Auburn University	USA
Stephen Wren	University of Oxford	UK
KHIN MAUNG BO	Northern Lincolnshire and Goole NHS Foundation Trust	UK
Mahmoud Kiaei	University of Arkansas for Medical Sciences	United States
Michael Ugrumov	Institute of Developmental Biology RAS	Russian Federation
Kimiko Inoue	Toneyama National Hospital	Japan
Caroline Corbel	Institut de Recherche Dupuy de Lome (IRDL)	France
Jong Wook Chang	Samsung Medical Center	Korea
Nicole Hess	University of New England	Australia
Udai Pandey	University of Pittsburgh Medical Center	USA
Gabriele Saretzki	Newcastle University	UK
Shinji Ohara	Matsumoto Medical Center	Japan
Cristine Alves da Costa	Institut de Pharmacologie Moléculaire et Cellulaire	France
Leonardo Pignataro	Columbia University-City University of New York-CSI	USA
Sabine Cordes	Lunenfeld-Tanenbaum Research Institute/Mt Sinai Hospital	Canada
Jeffrey Liddell	University of Melbourne	Australia
Niall Finnerty	Maynooth University	Ireland
Debashis Mukhopadhyay	Saha Institute of Nuclear Physics	India
Gilles Guillemin	Macquarie University	Australia
Abigail Takyi	University of Brighton	UK

Day 2: Speakers

Medvedev Svyatoslav	N.P.Bechtereva Institute of the Human Brain of the Russian Academy of Sciences	Russian Federation
Martin L. Pall	Washington State University	USA
Sergio Chieffi	Second University of Naples	Italy
Laura Calza	University of Bologna	Italy
Andrzej Pilc	Polish Academy of Sciences	Poland
Razvana Stanciu	Universite Libre de Bruxelles (ULB)	Belgium
Kathryn Commons	Children’s Hospital Boston-Harvard Medical School	USA
Caroline Lucke	Medical Campus University of Oldenburg	Germany
Sabrina Wang	National Yang-Ming University	Taiwan
Marta Nieto	Spanish National Research Council	Spain
Viviane Rostirola Elsner	IPA Methodist University	Brazil
K.L. Leenders	University of Groningen	The Netherlands
Leah K. Light	Brainchild Institute	USA
Kenneth Gaines	Vanderbilt University Medical Center	USA
Bruno Gonzalez	Inserm - U1245 Team NeoVasc	France
Raquel Sofia Marques Neves	Amana Healthcare Medical and Rehabilitation Hospital	UAE
Marina Vladimirovna Zueva	Moscow Helmholtz Research Institute of Eye Diseases	Russia
Laehyun Kim	Korea Institute of Science and Technology	Korea
Prokopenko Semen	Krasnoyarsk State Medical University	Russian Federation
Luyang Tao	Soochow University	China
Anna Bezdeneznykh	Krasnoyarsk State Medical University	Russian Federation
M.R. Graham	Llantarnam Health Care	UK
Serhiy Forostyak	Charles University	Czech Republic
Gladstone C McDowell	Integrated Pain Solutions	USA
Saema Ansar	Lund University	Sweden
Barbara R. Cardoso	University of Sao Paulo	Brazil
Hassan Ravari	Mashhad university of medical sciences	Iran

Day 3: Speakers

Lars Hakan Thorell	Linkoping University	Sweden
Martin Egerth	Lufthansa Aviation Training GmbH	Germany
Munzberg Mathias	BG Klinik Ludwigshafen	Germany
Cecilia Montanez	Centro de Investigacion y de Estudios Avanzados del IPN	Mexico
Moataz Mohamed Talaat Mohamed Kamel El Seminary	Cairo University	Egypt
Maria-Magdalena Georgescu	Louisiana State University	USA
Teruna J. Siahaan	The University of Kansas	USA
Toshiki Mizuno	Kyoto Prefectural University of Medicine	Japan
Katherine L Wisner	Northwestern University	USA
Meena Kumari	Kansas State University	USA
Magnus Gram	Lund University	Sweden
Joanna Czarzasta	University of Warmia and Mazury	Poland
Dennis J. Dlugos	University of Pennsylvania School of Medicine	USA
Lynda El-Hassar	Yale School of Medicine	USA
Hoi Ki Kate Lui	Tseung Kwan O Hospital	Hong Kong
Shuhei Yamaguchi	Shimane University	Japan
Victor Vvedensky	Kurchatov Institute	Russian Federation
Michael Luedtke	Johnson & Johnson	USA
Fatimah Alqarni	King Abdullah bin Abdulaziz University Hospital	Saudi Arabia
Bilgehan Atilgan ACAR	Sakarya University Faculty of Medicine	Turkey
Albekov Nurvadi	Chechen State University	Russia
Paul Chapple	Queen Mary University of London	UK
Turkan ACAR	Sakarya University Faculty of Medicine	Turkey

We once again thank all the participants for their wonderful involvement towards the event which helped us for successful execution of this event.

Upcoming Neurology and Addiction Conferences:

The Addiction Conference 2019 can convene the world’s leading researchers, trade executives, policy specialists, doctors, clinicians, academicians and patient advocates to outline the landscape and outlook for drugs and treatment used for addiction and behavioural health. GAB 2019 is scheduled during August 22-24, 2019 in London, UK.

Past Conference Information 2018

2^nd Edition of Neurology Conference 2018 Report:

Magnus Group takes a great pride in announcing the success of “2^nd Edition of International Conference on Neurology and Brain Disorders” (INBC 2018) which was held in Rome, Italy, during 04-06 June, 2018.

Neurology Congress 2018 witnessed a combination of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new fangled issues related to the field of Neurology. The extremely illustrious conference hosted by Magnus Group was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing there countries around the world.

For INBC 2018 Final Program: Click Here

For INBC 2018 Gallery: Click Here

Organizing Committee Neurology Conference 2018:

Stephen Grossberg	Boston University	USA
Harry W M Steinbusch	Maastricht University	Netherlands
P Hemachandra Reddy	Texas Tech University Health Sciences	USA
Anthony E. Kline	University of Pittsburgh	USA
Corina O. Bondi	University of Pittsburgh	USA
Maria-Magdalena Georgescu	Louisiana State University	USA
Marat Akhmet	Middle East Technical University	Turkey
Ken Ware	NeuroPhysics Therapy Institute and Research Centre	Australia
Ichiro Maruyama	Okinawa Institute of Science and Technology Graduate University	Japan
Fuyong Jiao	Xian Jiaotong Univeristy	China
Margarit Tadevosyan	Artmed Medical Rehabilitation Center	Armenia
Medvedev Svyatoslav	N.P.Bechtereva Institute of the Human Brain of the Russian academy of sciences	Russisa
Najib Murr	Southern Illinois University School of Medicine	USA

The Organizing Committee would like to thank the moderators Jodie Marquez, University of Newcastle, Hunter Medical Research Institute, Australia, Lucia Carvelli, Florida Atlantic University, USA for their contributions which ensued in smooth functioning of the conference.

The conference was boarded with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The best Part of the conference was the keynote forum by prominent scientists, gave their profitable contributions in the form of highly enlightening presentations and made the conference a best notch one.

Keynote Speakers:

Maria-Magdalena Georgescu	Louisiana State University	USA
Stephen Grossberg	Boston University	USA
Ken Ware	NeuroPhysics Therapy Institute and Research Centre	Australia
Corina O. Bondi	University of Pittsburgh	USA
Ichiro Maruyama	Okinawa Institute of Science and Technology Graduate University	Japan
Margarit Tadevosyan	Artmed Medical Rehabilitation Center	Armania
Svyatoslav Medvedev	N.P. Bechtereva Institute of the Human Brain of the Russian Academy of Sciences	Russia
P. Hemachandra Reddy	Texas Tech University Health Sciences	USA
Corina O. Bondi	University of Pittsburgh	USA
Najib Murr	SIU Medicine	USA
Viviane Elsner	IPA Methodist University	Porto Alegre-RS Brazil
Marat Akhmet	Middle East Technical University	Turkey

Magnus Group is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on engross the plenary sessions, workshops and special sessions in a expanded manner to make this conference an privileged Summit.

Neurology Conference 2018 Speaker Line Up:

Day 1 Speakers:

Stephen Grossberg	Boston University	USA
Ken Ware	NeuroPhysics Therapy Institute and Research Centre	Australia
Maria-Magdalena Georgescu	Louisiana State University	USA
Corina O. Bondi	University of Pittsburgh	USA
Harry W.M. Steinbusch	Maastricht University Medical Center	Netherlands
Floyd Thompson	Brain Rehabilation Center, North Florida/South Gergia Veterans Health Systems	USA
Luca Malfassi	La Cittadina Fondazione Studi e Ricerche Veterinarie	Romanengo, Italy
Karol S. Bruzik	The University of Illinois at Chicago	USA
Swetlana Sirko	Ludwig-Maximilians-University Munich	Germany
Vittorio Maglione	IRCCS Neuromed	Italy
Valida Isanova	Kazan State Medical University	Russia
Jodie Marquez	University of Newcastle	Australia
Anthony E. Kline	University of Pittsburgh	USA

Day 2 Speakers:

P. Hemachandra Reddy	Texas Tech University Health Sciences	USA
Ichiro Maruyama	Okinawa Institute of Science and Technology Graduate University	Japan
Svyatoslav Medvedev	N.P.Bechtereva Institute of the Human Brain of the russian academy of sciences	Russia
Margarit Tadevosyan	Artmed Medical Rehabilitation Center	Armania
CarolAnn Peterson	University of Southern California	USA
Ken Ware	NeuroPhysics Therapy Institute and Research Centre	Australia
Nicola Postol	University of Newcastle	Australia
Eleonora Palmieri	University in Macerata	Italy
Yasutoshi Koga	Kurume University Graduate School of Medicine	Japan
Eugenia V Gurevich	Vanderbilt University	USA
Arun L. Jayaraman	Mayo Clinic Arizona	USA

Posters:

Richard Francis	Royal united hospital	UK
Baranowska-Bosiacka Irena	Pomeranian Medical University in Szczecin	Poland
Marta Goschorsk	Pomeranian Medical University in Szczecin	Poland
Izabela Gutowska	Pomeranian Medical University in Szczecin	Poland
Hiroko IKESHIMA-KATAOKA	WASEDA University, Faculty of Science and Engineering	Japan
Hyun Im Moon	Bundang Jesaeng Hospital	Korea
Kruchinina Margarita Vitalievna	Research Institute of internal and Preventive Medicine- Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences	Russia
Wasik Agnieszka	Institute of Pharmacology PAS	Poland
Cesar Garcia-Cruz	Centro de Investigación y de Estudios Avanzados del IPN	México
Carlos Eduardo Monici Fernandes	Federal University	Brazil
Bruna Silva Marques	Federal University of Sao Carlos	Brazil
Zofia Rogoz	Institute of Pharmacology Polish Academy of Sciences	Poland
Kelly Regina Serafim	Center Universitary Central Paulista	Brazil
Bartłomiej Stańczykiewicz	Wroclaw Medical University	Poland
Choon-Gon Jang	Sungkyunkwan University	Korea
Howard. H. Fenn	Stanford University	USA
Keerthi Madhurya Kethireddi	East Sussex Healthcare NHS trust	UK
Bernadete Marcia Voichcoski	Technological Federal University of Parana/Electronica, Biomedical Engineering	Brazil
Dao Pan	Cincinnati Children’s Hospital Medical Center	USA
Anastassiya Perfilyeva	Institute of General Genetics and Cytology CS MES RK	Kazakhstan
Leyla Djansugurova	Institute of General Genetics and Cytology CS MES RK	Kazakhstan
Karine Bertoldi	Universidade Federal do Rio Grande do Sul, Porto Alegre	Brazil
Arjay Dannug	Makati Medical Center	Phillipnes

Day 3 Speakers:

Najib Murr	SIU Medecine	USA
Viviane Elsner	IPA Methodist University	Porto Alegre-RS Brazil
Marat Akhmet	Middle East Technical University	Turkey
Lucia Carvelli	Florida Atlantic University	USA
Yu Liu	Jinan University	China
Maurizio Petrarca	“Bambino Gesù” Children’s Hospital	Italy
Patrice Ntenga	Neurological Clinic of the National Teaching Hospital, FANN	Senegal
Lorena Rubio	Institute of Neurobiology, Universidad Nacional Autonoma de Mexico	Mexico

Delegates:

Kimberley Naylor	Central Otago Health Services Ltd	New Zealand
Christian Saleh	Rehab Basel Neuro	Switzerland
INCHUL JUNG	Daejeon University	Korea
Ho Choong	Campbell town Hospital	Australia
Dina Dimitrova Bayatova	Actavis EAD A Teva company	Bulgaria
Galini Georgiev Hristov	Actavis EAD A Teva company	Bulgaria
RADIANA KOLEVA KOLEVA	Actavis EAD A Teva company	Bulgaria
Nadka Ivanova Samardzhieva	Actavis EAD A Teva company	Bulgaria
Svetlana Alexandrova Beneva	Actavis EAD A Teva company	Bulgaria
Hristina Spiridonova Chilingirova – Ignatieva	Actavis EAD A Teva company	Bulgaria
David	CMDHB	New Zealand
Andrew Tidemann	Women's and Children's Hospital, Adelaide	Australia
MD MOSARRAF HOSSAIN	Uttara Adhunik Medical College	Bangladesh
Navid Tabibzadeh	Lehigh Valley Health Network	USA
JG Storosum	AMC	Netherlands
J Hoogendijk	UMCU	Netherlands
Heidi Muller	TNU, Aarhus University	Denmark
Betina Elfving	TNU, Aarhus University	Denmark
Armin Nikpour	University of Sydney	Australia
Jean Dore	University of Laval Canada	Canada

2nd Edition of Neurology Conference 2018 would not have been successful if it has not been supported by intercontinental, multi-professional steering committee.

We once again thank all the participants for their wonderful participation towards the event which helped us for effective accomplishment of this event.

Upcoming Neurology and Addiction Conferences:

Welcome message from Yael Abreu-Villaça, Rio De Janeiro, Brazil

Dear participants, it is a pleasure to welcome you to our meeting. There is a strong association between mental illnesses and substance use disorders. As an example, the rates of tobacco, alcohol, cannabis and cocaine use disorders are about three times higher in patients with schizophrenia when compared to the general population. Also, mental illness patients are more resistant to the strategies available for treatment, as well as show increased rates of relapse and re-hospitalization. These findings aggravate concerns regarding the gap in the knowledge of the biological bases that underlie this comorbidity. The use of animal models complement epidemiological studies, has translational potential and paves the way to studies that aim to identify more effective drugs in the treatment of these diseases. With that in mind, the scientific session “Dual diagnosis - mental illness co-occurring with substance abuse” will deepen the discussion of current hypotheses and mechanisms proposed to explain this association.

Professor. Yael Abreu-Villaça,

Rio De Janeiro,

Brazil

Welcome message from Sam Vaknin, Southern Federal University, Russia

Dear Colleagues, participants in the Global Conference on Addiction Medicine and Behavioral Health (London, August 2019).

Addiction is one of the hottest topics in psychology. The addictive personality has been linked to the biochemistry of the brain, to post-traumatic conditions, to substance abuse, to personality and mood disorders, and even to gender roles.

All these and many additional dimensions are covered in this conference. The cutting edge of research on specific addictions – from cigarettes to the internet – is coupled with animal and human case studies across the life-span, including in childhood and adolescence.

Addiction psychiatry and medical-neurological aspects are brought to the fore as well as the social implications of addictive behaviors and the costs to the individual, even when he or she embarks on a path of rehabilitation. The conference is rounded up with alternative approaches to addiction and new insights.

It is rare to gain this kind of thorough exposure to all these facets of this complex phenomenon of addiction in one place and in three days. I am looking forward to widening my horizons and enriching my knowledge substantially by listening to all of you attentively and learning throughout the conference.

Sam Vaknin,

Southern Federal University,

Russia

Quick Links

Conference Schedule

Time	Session
08:00 - 09:00	Registrations
09:00 - 10:30	Opening Ceremony and Introduction
10:30 - 11:00	Refreshments
11:00 - 12:30	Keynote Session I and Keynote Session II
12:30 - 13:30	Lunch with Table Discussions
15:00 - 15:30	Coffee Break
15:30 - 18:00	Oral Presentations I
13:30 - 15:00	Poster Presentations I

Time	Session
09:00 - 10:30	Keynote Session III and Key Note Session IV
10:30 - 11:00	Refreshments
11:00 - 12:30	Oral Presentations II
12:30 - 13:30	Lunch with Table Discussions
13:30 - 15:00	Poster Presentations II
15:00 - 15:30	Coffee Break
15:30 - 18:00	Oral Presentations III

Time	Session
09:00 - 10:30	Oral Presentations IV
10:30 - 11:00	Refreshments
11:00 - 12:30	Scientific Session V
12:30 - 13:30	Lunch with round table discussions
15:00 - 15:30	End Note Session and Closing Ceremony